• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于双氯芬酸透皮给药的古古勒脂质纳米囊泡的制备与评价

Formulation and evaluation of guggul lipid nanovesicles for transdermal delivery of aceclofenac.

作者信息

Gaur Praveen Kumar, Mishra Shikha, Aeri Vidhu

机构信息

Department of Pharmaceutics, I.T.S. Paramedical (Pharmacy) College, Muradnagar, Ghaziabad 201206, India.

Department of Pharmacognosy & Phytochemistry, Jamia Hamdard, New Delhi 110062, India.

出版信息

ScientificWorldJournal. 2014 Feb 6;2014:534210. doi: 10.1155/2014/534210. eCollection 2014.

DOI:10.1155/2014/534210
PMID:24672328
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3932823/
Abstract

CONTEXT

Most new drugs have low water solubility and liposome is an important formulation to administer such drugs; however, it is quite unstable and has negligible systemic absorption.

OBJECTIVE

Aceclofenac nanovesicles were made using guggul lipid for formulating stable transdermal formulation.

MATERIALS AND METHODS

Guggul lipid was formulated into vesicles along with cholesterol and dicetyl phosphate using film hydration method. The formulations were analyzed for physicochemical properties and stability. Then its skin permeation and anti-inflammatory activity were determined.

RESULTS

Both categories of vesicles (PC and GL) showed optimum physicochemical properties; however, accelerated stability study showed considerable differences. GL-1 was appreciably stable for over 6 months at 4 °C. Corresponding gels (PCG-1 and GLG-1) showed C max values at 4.98 and 7.32 μg/mL along with the Tmax values at 4 and 8 hours, respectively. GLG-1 inhibited edema production by 90.81% in 6 hours. Discussion. PC liposomes are unstable at higher temperature and upon longer storage. The formulation with higher lipid content (GL-1) showed good drug retention after 24 hours and appreciable stability both at higher temperature and for longer duration. Guggul lipid being a planar molecule might be stacked in vesicle wall with cholesterol.

CONCLUSION

The composition of the nanovesicle played an important role in stability and drug permeation. Guggul lipid is suitable for producing stable vesicles.

摘要

背景

大多数新药的水溶性较低,脂质体是这类药物给药的重要剂型;然而,它相当不稳定,全身吸收可忽略不计。

目的

使用古古勒脂制备醋氯芬酸纳米囊泡,以配制稳定的透皮制剂。

材料与方法

采用薄膜水化法将古古勒脂与胆固醇和磷酸二鲸蜡酯一起制成囊泡。对制剂的理化性质和稳定性进行分析。然后测定其皮肤渗透性和抗炎活性。

结果

两类囊泡(PC和GL)均表现出最佳的理化性质;然而,加速稳定性研究显示出相当大的差异。GL-1在4℃下6个月以上相当稳定。相应的凝胶(PCG-1和GLG-1)的Cmax值分别为4.98和7.32μg/mL,Tmax值分别为4和8小时。GLG-1在6小时内抑制水肿产生90.81%。讨论。PC脂质体在较高温度和较长储存时间下不稳定。脂质含量较高的制剂(GL-1)在24小时后显示出良好的药物保留率,在较高温度和较长时间内均具有相当的稳定性。古古勒脂作为平面分子可能与胆固醇堆叠在囊泡壁中。

结论

纳米囊泡的组成在稳定性和药物渗透中起重要作用。古古勒脂适合制备稳定的囊泡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17de/3932823/ed0553302710/TSWJ2014-534210.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17de/3932823/6742899f55f0/TSWJ2014-534210.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17de/3932823/b30f98fdf904/TSWJ2014-534210.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17de/3932823/dc4e81747c83/TSWJ2014-534210.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17de/3932823/11ef2d40bff3/TSWJ2014-534210.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17de/3932823/1651484fc6bf/TSWJ2014-534210.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17de/3932823/ed0553302710/TSWJ2014-534210.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17de/3932823/6742899f55f0/TSWJ2014-534210.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17de/3932823/b30f98fdf904/TSWJ2014-534210.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17de/3932823/dc4e81747c83/TSWJ2014-534210.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17de/3932823/11ef2d40bff3/TSWJ2014-534210.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17de/3932823/1651484fc6bf/TSWJ2014-534210.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17de/3932823/ed0553302710/TSWJ2014-534210.006.jpg

相似文献

1
Formulation and evaluation of guggul lipid nanovesicles for transdermal delivery of aceclofenac.用于双氯芬酸透皮给药的古古勒脂质纳米囊泡的制备与评价
ScientificWorldJournal. 2014 Feb 6;2014:534210. doi: 10.1155/2014/534210. eCollection 2014.
2
Development of aceclofenac nanovesicular system using biomaterial for transdermal delivery: physical characterization, ex vivo, in vivo, and anti-inflammatory studies.采用生物材料制备双氯芬酸纳米囊系统经皮给药:物理特性表征、体外、体内和抗炎研究。
J Biomater Sci Polym Ed. 2013;24(18):2126-41. doi: 10.1080/09205063.2013.828579. Epub 2013 Aug 14.
3
Preparation, characterization and permeation studies of a nanovesicular system containing diclofenac for transdermal delivery.载双氯芬酸钠的纳米囊泡系统的制备、表征及透皮研究。
Pharm Dev Technol. 2014 Feb;19(1):48-54. doi: 10.3109/10837450.2012.751406. Epub 2013 Jan 2.
4
Solid lipid nanoparticles of guggul lipid as drug carrier for transdermal drug delivery.古胶脂质固体脂质纳米粒作为透皮给药的药物载体。
Biomed Res Int. 2013;2013:750690. doi: 10.1155/2013/750690. Epub 2013 Aug 24.
5
Development of a new nanovesicle formulation as transdermal carrier: formulation, physicochemical characterization, permeation studies and anti-inflammatory activity.一种新型纳米囊泡制剂作为透皮载体的研发:制剂、理化特性、渗透研究及抗炎活性
Artif Cells Nanomed Biotechnol. 2014 Oct;42(5):323-30. doi: 10.3109/21691401.2013.827119. Epub 2013 Aug 15.
6
Ceramide-2 nanovesicles for effective transdermal delivery: development, characterization and pharmacokinetic evaluation.神经酰胺-2 纳米囊泡经皮给药的有效性研究:制备、表征和药代动力学评价。
Drug Dev Ind Pharm. 2014 Apr;40(4):568-76. doi: 10.3109/03639045.2013.782502. Epub 2013 Apr 3.
7
Preparation and evaluation of aceclofenac microemulsion for transdermal delivery system.用于透皮给药系统的醋氯芬酸微乳剂的制备与评价
Arch Pharm Res. 2002 Aug;25(4):534-40. doi: 10.1007/BF02976614.
8
Novel elastic membrane vesicles (EMVs) and ethosomes-mediated effective topical delivery of aceclofenac: a new therapeutic approach for pain and inflammation.新型弹性膜囊泡(EMV)和醇质体介导的醋氯芬酸有效局部递送:一种治疗疼痛和炎症的新方法。
Drug Deliv. 2016 Oct;23(8):3135-3145. doi: 10.3109/10717544.2016.1155244. Epub 2016 Mar 10.
9
Development of ibuprofen nanoliposome for transdermal delivery: Physical characterization, in vitro/in vivo studies, and anti-inflammatory activity.用于透皮给药的布洛芬纳米脂质体的研制:物理表征、体内外研究及抗炎活性
Artif Cells Nanomed Biotechnol. 2016;44(1):370-5. doi: 10.3109/21691401.2014.953631. Epub 2014 Sep 11.
10
Solid lipid nanoparticles (SLNs) gels for topical delivery of aceclofenac in vitro and in vivo evaluation.固体脂质纳米粒(SLNs)凝胶经皮递药体系中醋氯芬酸的体外和体内评价。
Curr Drug Deliv. 2013 Dec;10(6):656-66. doi: 10.2174/156720181006131125150023.

引用本文的文献

1
Plant Resin Delivery by Nanovectors as an Emerging Approach to Boost Solubility, Permeability and Bioavailability.纳米载体介导的植物树脂递送:提高溶解度、渗透性和生物利用度的新兴方法
Pharmaceutics. 2025 Jan 3;17(1):53. doi: 10.3390/pharmaceutics17010053.
2
Enhanced oral bioavailability of efavirenz by solid lipid nanoparticles: in vitro drug release and pharmacokinetics studies.固体脂质纳米粒提高依非韦伦的口服生物利用度:体外药物释放及药代动力学研究
Biomed Res Int. 2014;2014:363404. doi: 10.1155/2014/363404. Epub 2014 May 21.

本文引用的文献

1
Vesicles as a tool for transdermal and dermal delivery.囊泡作为经皮和真皮递送的工具。
Drug Discov Today Technol. 2005 Spring;2(1):67-74. doi: 10.1016/j.ddtec.2005.05.003.
2
Preparation, characterization and permeation studies of a nanovesicular system containing diclofenac for transdermal delivery.载双氯芬酸钠的纳米囊泡系统的制备、表征及透皮研究。
Pharm Dev Technol. 2014 Feb;19(1):48-54. doi: 10.3109/10837450.2012.751406. Epub 2013 Jan 2.
3
The genus Commiphora: a review of its traditional uses, phytochemistry and pharmacology.
乳香属植物:其传统用途、植物化学和药理学的综述。
J Ethnopharmacol. 2012 Jul 13;142(2):319-30. doi: 10.1016/j.jep.2012.05.025. Epub 2012 May 21.
4
Effective separation and analysis of E- and Z-guggulsterones in Commiphora mukul resin, guggulipid and their pharmaceutical product by high performance thin-layer chromatography-densitometric method.高效薄层色谱-密度法有效分离和分析 Commiphora mukul 树脂、guggulipid 及其药物制剂中的 E-和 Z-芝麻素
J Pharm Biomed Anal. 2011 Sep 10;56(2):240-5. doi: 10.1016/j.jpba.2011.05.021. Epub 2011 May 20.
5
Enhanced bioavailability of exemestane via proliposomes based transdermal delivery.通过基于前体脂质体的透皮给药提高依西美坦的生物利用度。
J Pharm Sci. 2011 Aug;100(8):3208-3222. doi: 10.1002/jps.22542. Epub 2011 Mar 14.
6
Ex vivo skin delivery of diclofenac by transcutol containing liposomes and suggested mechanism of vesicle-skin interaction.经皮递送双氯芬酸的透皮醇含药脂质体及其与皮肤相互作用的机制探讨。
Eur J Pharm Biopharm. 2011 May;78(1):27-35. doi: 10.1016/j.ejpb.2010.12.010. Epub 2010 Dec 15.
7
Evaluation of mucoadhesive hydrogels loaded with diclofenac sodium-chitosan microspheres for rectal administration.载双氯芬酸钠-壳聚糖微球的黏膜黏附性水凝胶的评价用于直肠给药。
AAPS PharmSciTech. 2010 Dec;11(4):1695-702. doi: 10.1208/s12249-010-9544-3. Epub 2010 Nov 25.
8
Guggullipid derivatives: synthesis and applications.古古拉脂质衍生物:合成与应用。
Chem Phys Lipids. 2010 May;163(4-5):362-6. doi: 10.1016/j.chemphyslip.2010.02.004. Epub 2010 Feb 25.
9
Targeted drug delivery of Rifampicin to the lungs: formulation, characterization, and stability studies of preformed aerosolized liposome and in situ formed aerosolized liposome.利福平肺部靶向递药系统的研究:预形成雾化脂质体和原位形成雾化脂质体的制剂、特性和稳定性研究。
Drug Dev Ind Pharm. 2010 Jun;36(6):638-46. doi: 10.3109/03639040903410300.
10
Formulation and evaluation of curcumin gel for topical application.用于局部应用的姜黄素凝胶的配方与评价
Pharm Dev Technol. 2009;14(1):80-9. doi: 10.1080/10837450802409438.